With funds reaching almost EUR 140 million and leveraging an additional €100 million from the pharmaceutical industry, the Commission rapidly allocated the funds to 13 research projects on potential treatments, vaccines and diagnostic tests, through an emergency procedure under Horizon 2020 and the Ebola+ call of the Innovative Medicines Initiative.
B'fondi li kważi laħqu EUR 140 miljun u li ingranew EUR100 miljun addizzjonali mill-industrija tal-farmaċewtika, il-Kummissjoni malajr allokat fondi lil 13-il proġett ta' riċerka fuq trattamenti potenzjali, tilqim u testijiet dijanjostiċi, permezz ta' proċedura ta' emerġenza taħt Orizzont 2020 u s-sejħa l-Ebola+ tal-Inizjattiva dwar Mediċini Innovattivi.